Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway.

Authors:
Guo M; Wang W; Bai W; Bai Z; Chen W and 2 more

Journal:
Can J Gastroenterol Hepatol

Publication Year: 2022

DOI:
10.1155/2022/6413783

PMCID:
PMC9576428

PMID:
36262827

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Can J Gastroenterol Hepatol

Abbreviation: Can J Gastroenterol Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matche…
Erman A; Sahakyan Y; Everett K and 6 more (2024) - Transparency Score: 3/6
Prevalence of Esophageal Eosinophilia, Eosinophilic Esophagitis, and Lymphocytic Gastritis in Child…
Alaifan MA; Khayat A; Bokhary RY and 4 more (2024) - Transparency Score: 2/6
Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest.
Wang Y; Ma L; Xue P and 6 more (2023) - Transparency Score: 3/6
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patient…
Di Cola S; Cusi G; Lapenna L and 6 more (2023) - Transparency Score: 2/6
Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication.
Lang A; Goff C; Montgomery A and 4 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that there are no conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"The authors would like to thank Hebei Key Laboratory for Chronic Diseases, Tangshan Key Laboratory for Preclinical and Basic Research on Chromic Diseases, School of Basic Medical Sciences, and North China University of Science and Technology for support. This work was supported by the Natural Science Foundation of Hebei Province (grant no. H2019209355), the Hebei Provincial Health Commission Office (grant no. G2019074), and the High-End Talent Funding Project in Hebei Province (grant no. A202003005)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025